-
Biotechs With Upcoming PDUFA Dates
Wednesday, July 18, 2012 - 3:09pm | 871On Tuesday, the FDA approved the second weight-loss drug in the last 13 years when it green-lighted Vivus' drug Qsymia. On Wednesday, VVUS shares have shot up more than 14 percent to $30.27. The approval of this drug and the excitement that it has created in the biotech investing community may...